1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline

C110H138N16O5 — CID 159714332

IUPAC1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline
SMILESCCCN(C)Cc1ccc2nc(C3CC3)nc(N3CCC(c4ccccc4OC)CC3)c2c1.COCCN(C)Cc1ccc2nc(C3CC3)nc(N3CCC(c4ccccc4OC)CC3)c2c1.CO[C@H]1CCN(c2ccc3nc(C4CC4)nc(N4CCC(c5ccccc5C)CC4)c3c2)C1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(CN(C)C)cc23)CC1
InChIInChI=1S/C28H36N4O2.C28H34N4O.C28H36N4O.C26H32N4O/c1-31(16-17-33-2)19-20-8-11-25-24(18-20)28(30-27(29-25)22-9-10-22)32-14-12-21(13-15-32)23-6-4-5-7-26(23)34-3;1-19-5-3-4-6-24(19)20-11-14-31(15-12-20)28-25-17-22(32-16-13-23(18-32)33-2)9-10-26(25)29-27(30-28)21-7-8-21;1-4-15-31(2)19-20-9-12-25-24(18-20)28(30-27(29-25)22-10-11-22)32-16-13-21(14-17-32)23-7-5-6-8-26(23)33-3;1-29(2)17-18-8-11-23-22(16-18)26(28-25(27-23)20-9-10-20)30-14-12-19(13-15-30)21-6-4-5-7-24(21)31-3/h4-8,11,18,21-22H,9-10,12-17,19H2,1-3H3;3-6,9-10,17,20-21,23H,7-8,11-16,18H2,1-2H3;5-9,12,18,21-22H,4,10-11,13-17,19H2,1-3H3;4-8,11,16,19-20H,9-10,12-15,17H2,1-3H3/t;23-;;/m.0../s1
InChIKeyMZFUILSHOUGHON-FYGZFEGNSA-N
MW1764.42 g/mol
LogP21.11
Rot. Bonds28

About 1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline

1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline (PubChem CID 159714332) has the molecular formula C110H138N16O5 and a molecular weight of 1764.42 g/mol. Its IUPAC name is 1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline.

Molecular Properties

Compound Name1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline
PubChem CID159714332
Molecular FormulaC110H138N16O5
Molecular Weight1764.42 g/mol
Exact Mass1763.10
IUPAC Name1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline
SMILESCCCN(C)Cc1ccc2nc(C3CC3)nc(N3CCC(c4ccccc4OC)CC3)c2c1.COCCN(C)Cc1ccc2nc(C3CC3)nc(N3CCC(c4ccccc4OC)CC3)c2c1.CO[C@H]1CCN(c2ccc3nc(C4CC4)nc(N4CCC(c5ccccc5C)CC4)c3c2)C1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(CN(C)C)cc23)CC1
InChIInChI=1S/C28H36N4O2.C28H34N4O.C28H36N4O.C26H32N4O/c1-31(16-17-33-2)19-20-8-11-25-24(18-20)28(30-27(29-25)22-9-10-22)32-14-12-21(13-15-32)23-6-4-5-7-26(23)34-3;1-19-5-3-4-6-24(19)20-11-14-31(15-12-20)28-25-17-22(32-16-13-23(18-32)33-2)9-10-26(25)29-27(30-28)21-7-8-21;1-4-15-31(2)19-20-9-12-25-24(18-20)28(30-27(29-25)22-10-11-22)32-16-13-21(14-17-32)23-7-5-6-8-26(23)33-3;1-29(2)17-18-8-11-23-22(16-18)26(28-25(27-23)20-9-10-20)30-14-12-19(13-15-30)21-6-4-5-7-24(21)31-3/h4-8,11,18,21-22H,9-10,12-17,19H2,1-3H3;3-6,9-10,17,20-21,23H,7-8,11-16,18H2,1-2H3;5-9,12,18,21-22H,4,10-11,13-17,19H2,1-3H3;4-8,11,16,19-20H,9-10,12-15,17H2,1-3H3/t;23-;;/m.0../s1
InChIKeyMZFUILSHOUGHON-FYGZFEGNSA-N
XLogP21.11
TPSA175.19 Ų
H-Bond Donors
H-Bond Acceptors21
Rotatable Bonds28
Heavy Atoms131
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001764.42
LogP ≤ 521.11
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1021

Analyze 1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(3S)-1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol
CID 118617781
2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-pyrrolidin-1-ylquinazoline;ethane
CID 144986165
ethane;ethyl 2-[[1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]piperidin-4-yl]-methylamino]acetate
CID 144986131
2-cyclopentyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine
CID 118617719
1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylpyrrolidin-3-amine;2-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl-methylamino]ethanol;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methyl-2-morpholin-4-ylethanamine;ethyl 2-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-methylamino]acetate
CID 159691838
2-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-methylamino]acetaldehyde
CID 144986141
ethane;N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-2-phenylquinazolin-6-amine
CID 144986130
2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-nitroquinazoline;ethane;4-(2-methoxyphenyl)piperidine;propane
CID 144986111
[1-[2-(1-fluorocyclopropyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-yl]methanol
CID 144986208
2-[1-[6-(1-amino-3-methoxypropyl)-2-cyclopropylquinazolin-4-yl]piperidin-4-yl]-N,N-dimethylaniline
CID 130339683
2-[[2-cyclopropyl-4-[4-(4-fluoro-2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-methylamino]ethanol
CID 118610435
(3R)-1-[2-(1-fluorocyclopropyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol
CID 130339637

Frequently Asked Questions

What is the IUPAC name of 1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline?
The IUPAC name of 1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline (CID 159714332) is 1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline.
What is the SMILES notation for 1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline?
The canonical SMILES for 1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline is CCCN(C)Cc1ccc2nc(C3CC3)nc(N3CCC(c4ccccc4OC)CC3)c2c1.COCCN(C)Cc1ccc2nc(C3CC3)nc(N3CCC(c4ccccc4OC)CC3)c2c1.CO[C@H]1CCN(c2ccc3nc(C4CC4)nc(N4CCC(c5ccccc5C)CC4)c3c2)C1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(CN(C)C)cc23)CC1.
What is the InChIKey of 1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline?
The InChIKey is MZFUILSHOUGHON-FYGZFEGNSA-N. The full InChI is InChI=1S/C28H36N4O2.C28H34N4O.C28H36N4O.C26H32N4O/c1-31(16-17-33-2)19-20-8-11-25-24(18-20)28(30-27(29-25)22-9-10-22)32-14-12-21(13-15-32)23-6-4-5-7-26(23)34-3;1-19-5-3-4-6-24(19)20-11-14-31(15-12-20)28-25-17-22(32-16-13-23(18-32)33-2)9-10-26(25)29-27(30-28)21-7-8-21;1-4-15-31(2)19-20-9-12-25-24(18-20)28(30-27(29-25)22-10-11-22)32-16-13-21(14-17-32)23-7-5-6-8-26(23)33-3;1-29(2)17-18-8-11-23-22(16-18)26(28-25(27-23)20-9-10-20)30-14-12-19(13-15-30)21-6-4-5-7-24(21)31-3/h4-8,11,18,21-22H,9-10,12-17,19H2,1-3H3;3-6,9-10,17,20-21,23H,7-8,11-16,18H2,1-2H3;5-9,12,18,21-22H,4,10-11,13-17,19H2,1-3H3;4-8,11,16,19-20H,9-10,12-15,17H2,1-3H3/t;23-;;/m.0../s1.
What are the key properties of 1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline?
1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline has a molecular weight of 1764.42 g/mol, XLogP of 21.11, 28 rotatable bonds, 0 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-N,N-dimethylmethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-2-methoxy-N-methylethanamine;N-[[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]methyl]-N-methylpropan-1-amine;2-cyclopropyl-6-[(3S)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline is sourced from PubChem (CID 159714332), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).